Emerging Concepts in Mesothelioma

Dear Colleagues,

Despite extensive research efforts, mesothelioma is still tremendously difficult to treat and mesothelioma incidence rates have not declined significantly despite asbestos bans in more developed countries, while a new incipient and protracted epidemic caused by alternate needle-shaped materials is likely. In these dreadful times, the molecular landscape, the potential treatment strategies, and hopes for the future for patients with mesothelioma are vague. We are pleased to invite you to contribute a piece of certainty to the volatile scenery of mesothelioma diagnosis and treatment in a Special Issued entitled “Emerging Concepts in Mesothelioma”, based on your excellent contributions and involvement in the field.

This Special Issue aims to summarize past understanding and recent progress in mesothelioma research and treatment, and to provide a platform for the guidance of future developments, i.e., molecular profiling, drug screening, patient subgroups and geno/phenotypes, trial design, personalized medicine, etc.

Original research, reviews, and opinion pieces are sought and the involvement of your collaborators and students is welcome. We propose a topic based on your achievements, but this is subject to change. We look forward to receiving your contributions.

Dr. Georgios T. Stathopoulos
Dr. Tonia Adamides
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.